Brainstorm Cell Therapeutics Inc. today announced the election of Malcolm S. Taub to its Board of Directors. Malcolm Taub has had a distinguished career in the practice of law in New York City for 34 years. He has had a varied practice ranging from complex Federal Securities matters, fraud litigation to real estate litigation. He has been a leader in Latin American securities matters and has served as a consultant to the Argentinean Stock Exchange. His investment firm provided consultation, as well as advice with respect to bringing foreign private entities public in the United States.
Mr. Taub has been teaching law at several colleges and universities, including the New York University Real Estate Institute, Long Island University and Marymount College. He is presently a Trustee of The Gateway Schools of New York; which is devoted to educating learning disabled children, as well as the Devereux Glenholme School in Washington, Connecticut.
When asked about the effect of the election of Taub, Brainstorm President Chaim Lebovits said, â€œWe are proud to have Mr. Taub join the Brainstorm team. His extensive legal, financial and business background will, with G-dâ€™s help, immensely contribute toward helping us to achieve our goals of further growth and success of the Company and its cause.â€
This appointment increases Brainstormâ€™s board of five members. In addition to Mr. Taub, the members of Brainstormâ€™s board include Dr. Irit Arbel, one of the founders of Brainstorm who served as its president until November 2004; Dr. Jonathan Javitt, who is also a Former White House Advisor; John Hopkins Professor; and Mr. Moshe Lion, a senior partner of Lion, Orlitzky and Co., a member of Moore Stephens International, who also served as Director General of the Israel Prime Ministerâ€™s Office, as well as an economic advisor to the Israel Prime Minister. The companyâ€™s previous plans to appoint Ambassador Daniel Ayalon to the board were changed of necessity when he was elected to the Israeli Knesset.